Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 3

Ketiapin ve valproik asit tedavisine bağlı olarak gelişen masif kreatin kinaz ve karaciğer enzim yüksekliği: Bir olgu sunumu

Massive creatine kinase and hepatic enzyme elevation due to quetiapine and valproic acid treatment: A case report

Pages
238–240
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The possible mechanisms underlying the CK elevation related with quetiapine and the symptoms that the clinicians should be careful about will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In literature, creatine kinase (CK) elevations related to treatment with atypical antipsychotics have been reported in several case studies.
📊
Key Findings & Data:In this paper, we present a case of a patient, whose previous and present medical histories showed a massive increase in serum CK and CK myoglobin-band (CK-MB) during quetiapine treatment and in alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT) and lactate dehydrogenase (LDH) levels during valproic acid treatment.
💡
Conclusion & Impact:The possible mechanisms underlying the CK elevation related with quetiapine and the symptoms that the clinicians should be careful about will be discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In literature, creatine kinase (CK) elevations related to treatment with atypical antipsychotics have been reported in several case studies. In this paper, we present a case of a patient, whose previous and present medical histories showed a massive increase in serum CK and CK myoglobin-band (CK-MB) during quetiapine treatment and in alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT) and lactate dehydrogenase (LDH) levels during valproic acid treatment. The possible mechanisms underlying the CK elevation related with quetiapine and the symptoms that the clinicians should be careful about will be discussed.

Özet

Literatürde atipik antipsikotik kullanımı ile gelişen kreatin kinaz (CK) yüksekliği ile ilgili birkaç vaka bildirimi bulunmaktadır. Bu bildirimde, geçmiş ve bugünkü öyküsünde ketiapin kullanımı ile serum CK ve CK-myoglobin-band (CK-MB) düzeylerinde; valproik asit kullanımıyla ise alanin aminotransferaz (ALT), aspartat aminotransferaz (AST) ve laktat dehidrogenaz (LDH) düzeylerinde aşırı artış gelişen bir hasta sunmaktayız. Ketiyapin ile ilişkili CK yükselmesinin altında yatan olası mekanizmalar ve klinisyenlerin dikkat etmesi gereken belirtiler tartışılacaktır

🔖

Cite This Article

ERDOĞAN, S., ÇELİKEL, F. Ç. (2012). Ketiapin ve valproik asit tedavisine bağlı olarak gelişen masif kreatin kinaz ve karaciğer enzim yüksekliği: Bir olgu sunumu. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 3, 238–240. https://ajindex.com/articles/292617

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Gaertner I, Altendorf K, Batra A, Gaertner HJ. Relevance of liver enzyme elevations with four different neuroleptics: A retrospective review of 7263 treatment courses. J Clin Psychopharmacol 2001; 21:215-222. 2.Ozcanli T, Erdogan A, Ozdemir S, Onen B, Ozmen M, Doksat K, Sonsuz A. Severe liver enzyme elevations after three years of olanzapine treatment: A case report and review of olanzapine associated hepatotoxicity. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1163-1166. 3.Klein JP, Fiedler U, Appel H, Quante A, Jockers-Scherübl MC. Massive creatine kinase elevations with quetiapine: report of two cases. Pharmacopsychiatry 2006; 239:39-40. 4.Bowden CL. Valproate. Schatzberg AF, Nemeroff CB, editors. In Textbook of Psychopharmacology. Third ed. Arlington: American Psychiatry Association; 2004. p. 567-81. 5.Gortney JS, Fagan A, Kissack JC. Neuroleptic malignant syndrome secondary to quetiapine. Ann Pharmacother 2009; 43:785-791. 6.Smith RP, Puckett BN, Crawford J, Elliott RL. Quetiapine overdose and severe rhabdomyolysis. J Clin Psychopharmacol 2004; 24:343. 7.Plesnicar BK, Lasic JK, Plesnicar A. Quetiapine and elevated creatine phosphokinase. Pharmacopsychiatry 2007; 40:203-204. 8.Himmerich H, Ehrlinger M, Hackenberg M, Löhr B, Nickel T. Possible case of quetiapine induced rhabdomyolysis in a patient with depression treated with fluoxetine. J Clin Psychopharmacol 2006; 26:676-677. 9.Bachmann CJ, Nicksch B, de Lange D, Theisen FM, Remschmidt H. Repeated creatine kinase elevation under treatment with quetiapine, clozapine and aripiprazole in an adolescent. J Clin Psychopharmacol 2007; 27:710-711. 10.Lieberman JA. Quetiapine. Schatzberg AF, Nemeroff CB, editors. In Textbook of Psychopharmacology. Third ed. Arlington: American Psychiatry Association; 2004. p. 473-86. 11. Meltzer HY. Massive serum creatine kinas increases with atypical antipsychotic drugs: What is the mechanism and the message? Psychopharmacology (Berl) 2000; 150:349-350. 12. Devarajan S, Dursun SM. Antipsychotic drugs, serum creatine kinase (CPK) and possible mechanisms. Psychopharmacology (Berl) 2000; 152:122. 13. Meltzer HY, Cola PA, Parsa M. Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacology 1996; 15:395-405.